Breaking News
CD10 expression predicts tumor progression and poor prognosis in malignant melanoma
CD10 expression predicts tumor progression and poor prognosis in malignant melanoma
CD expression was examined in primary malignant melanoma (MM; n = 64); metastatic MM (n = 20) and new melanocytic nevi (n = 40) to determine whether it could serve as a marker...
Last updated: Thursday, February 23, 2012
AccessDermatology | © Copyright 2012 Prous Science S.A.U. a Thomson Reuters business or its licensors.
All rights reserved. Legal Information. Send your comments to Webmaster
ISSN 2013-8202
This website is optimized for Explorer 7.0 and above, Firefox 3.0, Safari, and Chrome. Content remains viewable in older versions, but loss of formatting and design elements may occur.
This site complies with the HONcode standard for trustworthy health information:
verify here.